ZA200210411B - Novel heteroaryl derivatives and the use thereof as pharmaceuticals. - Google Patents

Novel heteroaryl derivatives and the use thereof as pharmaceuticals.

Info

Publication number
ZA200210411B
ZA200210411B ZA200210411A ZA200210411A ZA200210411B ZA 200210411 B ZA200210411 B ZA 200210411B ZA 200210411 A ZA200210411 A ZA 200210411A ZA 200210411 A ZA200210411 A ZA 200210411A ZA 200210411 B ZA200210411 B ZA 200210411B
Authority
ZA
South Africa
Prior art keywords
pharmaceuticals
heteroaryl derivatives
novel heteroaryl
novel
derivatives
Prior art date
Application number
ZA200210411A
Other languages
English (en)
Inventor
Peter Emig
Eckhard Guenther
Bernd Nickel
Silke Baasner
Gerald Bacher
Thomas Beckers
Beate Aue
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of ZA200210411B publication Critical patent/ZA200210411B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200210411A 2000-07-21 2002-12-23 Novel heteroaryl derivatives and the use thereof as pharmaceuticals. ZA200210411B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10035927A DE10035927A1 (de) 2000-07-21 2000-07-21 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ZA200210411B true ZA200210411B (en) 2003-02-26

Family

ID=7649979

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200210411A ZA200210411B (en) 2000-07-21 2002-12-23 Novel heteroaryl derivatives and the use thereof as pharmaceuticals.

Country Status (28)

Country Link
US (1) US6706722B2 (enExample)
EP (1) EP1301485B1 (enExample)
JP (1) JP2004504382A (enExample)
KR (1) KR20030022296A (enExample)
CN (1) CN1296359C (enExample)
AR (1) AR033383A1 (enExample)
AT (1) ATE365717T1 (enExample)
AU (2) AU8967501A (enExample)
BG (1) BG107507A (enExample)
BR (1) BR0112591A (enExample)
CA (1) CA2353360A1 (enExample)
CY (1) CY1106890T1 (enExample)
CZ (1) CZ2003427A3 (enExample)
DE (2) DE10035927A1 (enExample)
DK (1) DK1301485T3 (enExample)
ES (1) ES2291349T3 (enExample)
HU (1) HUP0303729A3 (enExample)
IL (1) IL153476A0 (enExample)
MX (1) MXPA02012564A (enExample)
NO (1) NO324939B1 (enExample)
NZ (1) NZ524155A (enExample)
PL (1) PL358808A1 (enExample)
PT (1) PT1301485E (enExample)
RU (1) RU2267488C2 (enExample)
SK (1) SK1932003A3 (enExample)
UA (1) UA75085C2 (enExample)
WO (1) WO2002008194A1 (enExample)
ZA (1) ZA200210411B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
EP1517898A1 (de) * 2002-06-29 2005-03-30 Zentaris GmbH Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und b sartiger tumorerkrankungen
JP2005537258A (ja) * 2002-07-17 2005-12-08 ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規アントラセン誘導体及び医薬品としてのその使用
US7125461B2 (en) * 2003-05-07 2006-10-24 L & L Products, Inc. Activatable material for sealing, baffling or reinforcing and method of forming same
FR2855825B1 (fr) * 2003-06-04 2008-08-22 Aventis Pharma Sa Produits aryl-heteroaromatiques, compositions les contenant et utilisation
AR044586A1 (es) * 2003-06-04 2005-09-21 Aventis Pharma Sa Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion
US7249415B2 (en) * 2003-06-26 2007-07-31 Zephyros, Inc. Method of forming members for sealing or baffling
DE10331500A1 (de) * 2003-07-11 2005-02-24 Zentaris Gmbh Neue Acridin-Derivate und deren Verwendung als Arzneimittel
AU2006209079A1 (en) * 2005-01-27 2006-08-03 Alma Mater Studiorum-Universita' Di Bologna Organic compounds useful for the treatment of Alzheimer's disease, their use and method of preparation
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
CA2678577A1 (en) * 2007-02-26 2008-09-04 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
US8575156B2 (en) * 2007-07-26 2013-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) * 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
EP2252598A2 (en) * 2008-02-11 2010-11-24 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8598160B2 (en) * 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
CA2718264A1 (en) * 2008-03-18 2009-09-24 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
TW201004945A (en) 2008-05-01 2010-02-01 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
NZ588954A (en) 2008-05-01 2012-08-31 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291373B1 (en) * 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CN104327062A (zh) 2008-07-25 2015-02-04 贝林格尔·英格海姆国际有限公司 11β-羟基类固醇脱氢酶1的环状抑制剂
EP2393807B1 (en) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
GEP20156309B (en) * 2009-04-30 2015-07-10 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド 置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
EA201300522A1 (ru) 2010-11-02 2013-11-29 Бёрингер Ингельхайм Интернациональ Гмбх Фармацевтические комбинации для лечения метаболических нарушений

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
US4937246A (en) * 1987-11-25 1990-06-26 Takeda Chemical Industries, Ltd. PAF antagonist, 1,4-disubstituted piperazine compounds and production thereof
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
RU2126001C1 (ru) * 1995-01-10 1999-02-10 Самдзин Фармасьютикал Ко., Лтд Производные пиперазина и фармацевтическая композиция на их основе
DE69722360T2 (de) * 1996-06-29 2003-11-27 Samjin Pharm, Co. Piperazin-derivate und verfahren zu ihrer herstellung
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
FR2753706B1 (fr) 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE19743435A1 (de) 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
IL141724A0 (en) 1998-08-28 2002-03-10 Scios Inc INHIBITORS OF P38-α KINASE
JP2002538121A (ja) 1999-03-03 2002-11-12 メルク エンド カムパニー インコーポレーテッド プレニルタンパク質トランスフェラーゼの阻害剤

Also Published As

Publication number Publication date
CZ2003427A3 (cs) 2003-06-18
PL358808A1 (en) 2004-08-23
SK1932003A3 (en) 2003-10-07
UA75085C2 (en) 2006-03-15
ES2291349T3 (es) 2008-03-01
AR033383A1 (es) 2003-12-17
ATE365717T1 (de) 2007-07-15
WO2002008194A1 (de) 2002-01-31
CN1296359C (zh) 2007-01-24
AU8967501A (en) 2002-02-05
DE50112669D1 (de) 2007-08-09
EP1301485B1 (de) 2007-06-27
AU2001289675B2 (en) 2005-04-07
CA2353360A1 (en) 2002-01-21
EP1301485A1 (de) 2003-04-16
JP2004504382A (ja) 2004-02-12
MXPA02012564A (es) 2003-09-22
US20020132821A1 (en) 2002-09-19
HUP0303729A2 (hu) 2004-03-01
RU2267488C2 (ru) 2006-01-10
HUP0303729A3 (en) 2009-01-28
CN1443172A (zh) 2003-09-17
WO2002008194A8 (de) 2003-05-08
PT1301485E (pt) 2007-08-30
KR20030022296A (ko) 2003-03-15
NZ524155A (en) 2005-04-29
DE10035927A1 (de) 2002-03-07
BG107507A (bg) 2003-09-30
BR0112591A (pt) 2003-07-22
NO20030301L (no) 2003-03-11
CY1106890T1 (el) 2012-09-26
HK1057549A1 (en) 2004-04-08
DK1301485T3 (da) 2007-11-05
NO324939B1 (no) 2008-01-07
NO20030301D0 (no) 2003-01-20
IL153476A0 (en) 2003-07-06
US6706722B2 (en) 2004-03-16

Similar Documents

Publication Publication Date Title
ZA200210180B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
ZA200210411B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
AU2001279757A1 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals
AU2001289675A1 (en) Novel Heteroaryl Derivatives and the Use Thereof as Pharmaceuticals
ZA200300545B (en) Novel heteroaryl derivatives and use thereof as anti-tumour agents.
HUP0104917A3 (en) Azepinoindole derivatives, the production and use thereof
IL148545A0 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
ZA200104196B (en) Azepinoindole derivatives, the production and use thereof.
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
HUP0401648A3 (en) 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
AP2001002250A0 (en) Pharmaceuticals
MXPA03000644A (es) Nuevos derivados de indol y uso como medicamentos.
AU2001294240A1 (en) 2,2-diphenylbutanamide derivatives and medicines containing the same
AU2002235883A1 (en) 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and the use thereof as pesticides
IL149993A0 (en) Novel heteroaryl derivatives, their preparation and use
ZA200109571B (en) Novel compounds, their use and preparation.
MXPA03006744A (es) Derivados sustituidos de propan-1,3-diamina y su uso farmaceutico.
SI1301485T1 (sl) Derivati akridina in njihova uporaba kot zdravila
IL160606A0 (en) C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
IL160608A0 (en) C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
HRP20020971A2 (en) 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors
GB0031526D0 (en) Novel pharmaceuticals
ZA200403665B (en) Aryloxyphenyl and arylsulfanylphenyl derivatives.